Sort   by:  
 Page size 
UnknownSplicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe disease.
Not available
S-EPMC12008586 | biostudies-literature
UnknownEnterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
Not available
S-EPMC12069150 | biostudies-literature
UnknownProteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl.
Not available
S-EPMC8630778 | biostudies-literature
UnknownRole of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study.
Not available
S-EPMC6064187 | biostudies-literature
UnknownStuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40.
Not available
S-EPMC10689913 | biostudies-literature
UnknownEarly developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial.
Not available
S-EPMC3341507 | biostudies-literature
UnknownRefined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
Not available
S-EPMC6263168 | biostudies-literature
UnknownRelative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells.
Not available
S-EPMC5364806 | biostudies-literature
UnknownReal-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Not available
S-EPMC8357697 | biostudies-literature
UnknownSystems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma.
Not available
S-EPMC7564419 | biostudies-literature
Sort   by:  
 Page size